Malaysia Approves AstraZeneca + Sinovac COVID Vaccines!

Malaysia has conditionally approved the AstraZeneca and Sinovac finished vaccines against COVID-19!

This does NOT include the bulk Sinovac vaccine that will undergo fill and finish by Pharmaniaga.

Find out this means for the COVID-19 vaccination program in Malaysia!


Malaysia Approves AstraZeneca + Sinovac COVID Vaccines!

On 2 March 2021, the Malaysia Ministry of Health announced that the AstraZeneca and Sinovac vaccines against COVID-19 received conditional approval.

  1. AstraZeneca COVID-19 Vaccine Solution for Injection
    Registrant : AstraZeneca Sdn. Bhd.
    Manufacturer : Medimmune Pharma B.V., Netherlands
  2. Sinovac CoronaVac Suspension for Injection
    Registrant : Pharmaniaga Lifescience Sdn. Bhd.
    Manufacturer : Sinovac Life Sciences Co. Ltd., China

These conditional approvals would allow the AstraZeneca and Sinovac finished vaccines to be used in the Malaysia COVID-19 vaccination program.

However, please note that the conditional approval is only for the finished vaccine from Sinovac.

The NPRA is still evaluating the CoronaVac vaccine that is being filled and finished by Pharmaniaga LifeScience Sdn. Bhd.

Hence, the bulk CoronaVac vaccine that recently arrived in Malaysia has NOT been approved for use yet.

They also gave conditional approval to a second source of the Pfizer COVID-19 vaccine.

  1. COMIRNATY Concentrate for Dispersion for Injection
    Registrant : Pfizer (M) Sdn. Bhd.
    Manufacturer #1 (drug product and final release) : Pfizer Manufacturing Belgium NV, Puurs, Belgium
    Manufacturer #2 (final release) : BioNTech Manufacturing GmbH, Mainz, Germany

The Pfizer COMIRNATY vaccine had earlier been approved. This additional approval allows vaccine doses from the BioNTech manufacturing facility in Germany to be used in the Malaysia COVID-19 vaccination program.

The NPRA is still evaluating the Sputnik V vaccine, also known as Gam-COVID-Vac, from Russia’s Gamaleya Research Institute.


AstraZeneca + Sinovac Vaccines : A Quick Primer!

The AstraZeneca COVID-19 vaccine, codenamed AZD1222, is a viral vector vaccine.

It uses a chimpanzee adenovirus – ChAdOx1 – which has been modified to prevent replication, to introduce a DNA sequence of the SARS-CoV-2 spike protein.

Once injected, the vaccine enters the cell and “teaches” it to produce the SARS-CoV-2 spike proteins and express them on its surface.

These spike proteins triggers the immune response to create antibodies that will protect you against the real SARS-CoV-2 virus.

The Sinovac COVID-19 vaccine, branded CoronaVac, is an inactivated virus vaccine.

It uses actual SARS-CoV-2 virus grown in Vero cells, and then killed using β-propiolactone.

Once injected into the body, the antigens on the inactivated SARS-CoV-2 virus triggers the body’s immune system.

Recommended : CoronaVac Vaccine By Sinovac : Your Questions Answered!


Recommended Reading

Go Back To > Business | HealthcareHome


Support Tech ARP!

If you like our work, you can help support us by visiting our sponsors, participating in the Tech ARP Forums, or even donating to our fund. Any help you can render is greatly appreciated!

Leave a ReplyCancel reply